| Structure | Chemical Name | CAS | MF |
|
Imatinib Impurity 2
|
1384131-91-2
|
C7H11NO
|
|
2,3,5-Trifluorocinnamic acid
|
1384157-92-9
|
C9H5F3O2
|
|
3,3-Dimethoxy-2,15,18-trioxane-3-silaundecane
|
1384163-86-3
|
C17H38O5Si
|
|
EsoMeprazole IMpurity 1
|
1384163-92-1
|
C16H17N3O2
|
|
4-Chloro-7-phenylquinazoline
|
1384182-07-3
|
C14H9ClN2
|
|
Benzofuro[3,2-b]pyridine, 8-bromo-
|
1384187-12-5
|
C11H6BrNO
|
|
(S)-Indacaterol
|
1384188-70-8
|
C24H29ClN2O3
|
|
5-BroMo-2-(3-Methoxyphenoxy)-1,3-thiazole
|
1384191-70-1
|
C10H8BrNO2S
|
|
5-Bromo-6-chloro-1H-indol-3-yl-a-D-mannopyranoside
|
1384197-50-5
|
C14H15BrClNO6
|
|
2-chloro-5-(trifluoromethyl)thiazole
|
1384199-31-8
|
C4HClF3NS
|
|
Triphenylene, 2-(3-chlorophenyl)-
|
1384206-44-3
|
C24H15Cl
|
|
7H-Benzo[c]fluorene, 9-bromo-7,7-diphenyl-
|
1384207-26-4
|
C29H19Br
|
|
Lesinurad Impurity 5 Sodium Salt
|
1384208-36-9
|
C17H15N3O3S
|
|
4-Pyridinamine, 2,6-dibromo-3-chloro-
|
1384213-52-8
|
C5H3Br2ClN2
|
|
{[5-chloro-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}dimethylamine
|
1384216-47-0
|
C15H23BClNO2
|
|
SOTA-008
|
1384242-55-0
|
C20H23ClO6
|
|
SOTA-009
|
1384242-56-1
|
C28H31ClO10
|
|
5'-O-(4,4'-Dimethoxytrityl)-2'-O-(2-methoxyethyl) adenosine
|
1384253-67-1
|
C34H37N5O7
|
|
Rivaroxaban Impurity 55
|
1384257-81-1
|
C8H9Cl2NO2S
|
|
Aducanumab
|
1384260-65-4
|
|
|
Fmoc-Ala-Ala-PAB
|
1384263-83-5
|
C28H29N3O5
|
|
tert-Butyl N-(1-methyl-2-oxopyrrolidin-3-yl)carbamate
|
1384264-11-2
|
C10H18N2O3
|
|
Methyl 2-amino-2-(oxetan-3-yl)acetate hydrochloride
|
1384264-13-4
|
C6H12ClNO3
|
|
Methyl 6-aminoindoline-2-carboxylate dihydrochloride
|
1384264-16-7
|
C10H14Cl2N2O2
|
|
(1-(6-Chloro-pyridin-2-yl)cyclopropyl)amine
|
1384264-20-3
|
C8H9ClN2
|
|
Methyl 1-(3-chlorophenyl)-4-oxocyclohexanecarboxylate
|
1384264-35-0
|
C14H15ClO3
|
|
Methyl 1-(3-fluorophenyl)-4-oxocyclohexanecarboxylate
|
1384264-42-9
|
C14H15FO3
|
|
1-(5-chloro-3-fluoropyridin-2-yl)ethanaMine
|
1384264-43-0
|
C7H8ClFN2
|
|
ethyl 5-chloro-6-(chloroMethyl)nicotinate hydrochloride
|
1384264-44-1
|
C9H10Cl3NO2
|
|
4-(Azetidin-3-yl)pyrimidine 2HCl
|
1384264-47-4
|
C7H10ClN3
|
|
1-(5-(Trifluoromethyl)pyridin-2-yl)cyclopropanamine 2HCl
|
1384264-48-5
|
C9H11Cl2F3N2
|
|
3-(4-Bromophenyl)azetidin-3-amine 2HCl
|
1384264-75-8
|
C9H12BrClN2
|
|
Methyl 1-(4-methoxyphenyl)-4-oxocyclohexanecarboxylate
|
1384264-82-7
|
C15H18O4
|
|
Methyl 1-(3,4-dichlorophenyl)-4-oxocyclohexanecarboxylate
|
1384264-84-9
|
C14H14Cl2O3
|
|
1-(3-broMo-5-chloropyridin-2-yl)-2-chloroethanone
|
1384264-88-3
|
C7H4BrCl2NO
|
|
3-broMo-5-chloro-2-fluoroaniline HCl
|
1384265-18-2
|
C6H5BrCl2FN
|
|
1-(5-Bromopyridin-2-yl)cyclopropanamine dihydrochloride
|
1384265-23-9
|
C8H10BrClN2
|
|
Methyl 1-(4-BroMophenyl)-4-oxocyclohexanecarboxylate
|
1384265-30-8
|
C14H15BrO3
|
|
2-(7-(tert-butoxycarbonyl)-7-azaspiro[3.5]nonan-2-yl)acetic acid
|
1384265-35-3
|
C15H25NO4
|
|
6-Chloro-2,3-dihydro-benzofuran-3-ylamine hydrochloride
|
1384265-38-6
|
C8H9Cl2NO
|
|
6-Cyano-2,3-difluoroaniline, 3,4-Difluoroanthranilonitrile
|
1384265-40-0
|
C7H4F2N2
|
|
7-Chloro-2-iodoimidazo[1,2-a]pyridine
|
1384265-42-2
|
C7H4ClIN2
|
|
Methyl 1-(2-Fluorophenyl)-4-oxocyclohexanecarboxylate
|
1384265-52-4
|
C14H15FO3
|
|
4-Fluoro-2,3-dihydrobenzofuran-3-amine HCl
|
1384265-54-6
|
C8H9ClFNO
|
|
6-Chloro-1,2-dihydropyrazolo[3,4-d]pyriMidin-3-one
|
1384265-61-5
|
C5H3ClN4O
|
|
SYP-5
|
1384268-04-5
|
C18H16O3S
|
|
(S)-3-(4-Fluorophenyl)pyrrolidine hydrochloride
|
1384268-53-4
|
C10H13ClFN
|
|
(S)-3-(4-Chlorophenyl)pyrrolidine HCl
|
1384268-58-9
|
C10H13Cl2N
|
|
(S)-3-(Cbz-amino)-azepane HCl
|
1384268-59-0
|
C14H21ClN2O2
|
|
(R)-3-(4-Bromophenyl)pyrrolidine HCl
|
1384268-64-7
|
C10H13BrClN
|
|
(R)-1-tert-Butyl 3-ethyl 4-benzyl-5-oxopiperazine-1,3-dicarboxylate
|
1384268-70-5
|
C19H26N2O5
|
|
(S)-3-(4-Bromophenyl)pyrrolidine HCl
|
1384268-82-9
|
C10H13BrClN
|
|
(R)-tert-Butyl 4-benzyl-3-(hydroxymethyl)-5-oxopiperazine-1-carboxylate
|
1384268-90-9
|
C17H24N2O4
|
|
(R)-3-(3,4-Dichlorophenyl)pyrrolidine HCl
|
1384269-00-4
|
C10H12Cl3N
|
|
(3S,4S,5S,6S)-2-(methoxycarbonyl)-6-(p-tolylthio)tetrahydro-2H-pyran-3,4,5-triyl tris(2-methylpropanoate)
|
1384270-00-1
|
C26H36O9S
|
|
Benzenamine, N,?N-?bis[4-?(octyloxy)?phenyl]?-?4-?(4,?4,?5,?5-?tetramethyl-?1,?3,?2-?dioxaborolan-?2-?yl)?
|
1384270-52-3
|
C40H58BNO4
|
|
Tetrazine active ester (Tetrazine-NHS)
|
1384271-41-3
|
C17H11N7O4
|
|
Cyclopropanol, 2-(4-penten-1-yl)-,(1R,2R)-rel-
|
1384277-05-7
|
C8H14O
|
|
9-Benzyl-2,7-dibromo-9H-carbazole
|
1384281-49-5
|
C19H13Br2N
|
|
Boronic acid, B-?[4-?[bis[4-?(octyloxy)?phenyl]?amino]?phenyl]?-
|
1384289-47-7
|
C34H48BNO4
|
|
N-(3,5-dichlorophenyl)cinnamamide
|
1384289-76-2
|
C15H11Cl2NO
|
|
tert-butyl N-[3-chloro-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbamate
|
1384312-60-0
|
C17H25BClNO4
|
|
Methyl (3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbaMate
|
1384313-38-5
|
C14H20BNO4
|
|
benzyl(S)-azepan-3-ylcarbamate
|
1384421-60-6
|
C14H20N2O2
|
|
(1R,5S)-tert-butyl 3,6-diazabicyclo[3.1.1]heptane-6-carboxylate hydrochloride
|
1384424-52-5
|
C10H18N2O2.ClH
|
|
1-(7-Methoxyquinolin-4-yl)-3-[6-(trifluoromethyl)pyridin-2-yl]urea
|
1384424-80-9
|
C17H13F3N4O2
|
|
(E)-3-(3-bromo-4,5-dihydroxyphenyl)-N-(3,4,5-trihydroxybenzyl)prop-2-enethioamide
|
1384426-12-3
|
C16H14BrNO5S
|
|
5-(difluoromethyl)-1,3-dimethyl-1H-pyrazole-4-carboxylic acid
|
1384427-29-5
|
C7H8F2N2O2
|
|
Morpholine, 2-(tetrahydro-2-furanyl)-
|
1384427-35-3
|
C8H15NO2
|
|
4-aminobicyclo[2.2.1]heptane-1-carboxylic acid hydrochloride
|
1384427-36-4
|
C8H14ClNO2
|
|
ethyl 2-amino-3-(pyridin-4-yl)propanoate 2hcl
|
1384427-38-6
|
C10H16Cl2N2O2
|
|
[(3-bromophenyl)methyl]hydrazine hydrochloride
|
1384427-52-4
|
C7H10BrClN2
|
|
methyl 2-[(prop-2-en-1-yl)amino]-1,3-thiazole-5-carboxylate
|
1384427-58-0
|
C8H10N2O2S
|
|
2-Oxa-7-azaspiro[4.4]nonan-8-one
|
1384427-76-2
|
C7H11NO2
|
|
1-(2-Methoxyethyl)-5-(trifluoromethyl)-1H-1,2,3-triazole-4-carboxylic acid
|
1384427-78-4
|
C7H8F3N3O3
|
|
1,1-Difluoropropan-2-amine hydrochloride
|
1384427-90-0
|
C3H8ClF2N
|
|
(cyclobutylmethyl)(2,2-difluoroethyl)amine hydrochloride
|
1384427-97-7
|
C7H14ClF2N
|
|
1-Cyclopropanesulfonyl-piperidin-4-ylamine hydrochloride
|
1384428-03-8
|
C8H17ClN2O2S
|
|
2-Amino-3-fluoropropan-1-ol hydrochloride
|
1384428-30-1
|
C3H9ClFNO
|
|
4-(fluorosulfonyl)thiophene-2-carboxylic acid
|
1384428-37-8
|
C5H3FO4S2
|
|
(4-Methyloxan-4-yl)methanamine hydrochloride
|
1384428-40-3
|
C7H16ClNO
|
|
4-(2,2,2-Trifluoroethyl)piperidine hydrochloride
|
1384428-45-8
|
C7H13ClF3N
|
|
2-Cyclopropylcyclopropan-1-amine
|
1384428-88-9
|
C6H12ClN
|
|
2-(1-aminocyclobutyl)acetamide hydrochloride
|
1384428-91-4
|
C6H13ClN2O
|
|
3-(propan-2-yl)pyrrolidine hcl
|
1384429-21-3
|
C7H16ClN
|
|
3-tert-butoxyazetidine hydrochloride
|
1384429-32-6
|
C7H16ClNO
|
|
2-amino-2-(oxolan-3-yl)ethan-1-ol hydrochloride
|
1384429-43-9
|
C6H14ClNO2
|
|
(4-fluoro-3,5-dimethylphenyl)methanamine
|
1384429-44-0
|
C9H12FN
|
|
3-(4-chlorophenyl)cyclobutane-1-carboxylic acid
|
1384429-60-0
|
C11H11ClO2
|
|
2-fluorobutan-1-amine hydrochloride
|
1384429-67-7
|
C4H11ClFN
|
|
3-Iodo-imidazo[1,2-a]pyridine-6-carboxylic acid
|
1384429-70-2
|
C8H5IN2O2
|
|
1-(1H-imidazol-2-yl)propan-1-amine dihydrochloride
|
1384429-75-7
|
C6H12ClN3
|
|
2-(2-amino-3,3-dimethylbutoxy)-1,3-dimethylbenzene hydrochloride
|
1384429-91-7
|
C14H24ClNO
|
|
3-Iodo-imidazo[1,2-a]pyridine-8-carboxylic acid
|
1384429-92-8
|
C8H5IN2O2
|
|
2-amino-2-cyclopentylacetonitrile hydrochloride
|
1384429-97-3
|
C7H13ClN2
|
|
2-(1-methyl-1H-1,2,4-triazol-3-yl)ethanamine hydrochloride
|
1384430-52-7
|
C5H11ClN4
|
|
N-(Cyclopropylmethyl)-2,2-difluoroethanamine hydrochloride
|
1384430-62-9
|
C6H12ClF2N
|
|
2-(1,2,4-Oxadiazol-5-yl)ethan-1-amine hydrochloride
|
1384430-69-6
|
C4H8ClN3O
|
|
Pyrimidine, 2-(chloromethyl)-5-methyl-, hydrochloride (1:1)
|
1384430-75-4
|
C6H8Cl2N2
|
|
[1-(4-methoxyphenyl)-1H-1,2,3-triazol-4-yl]methanamine hydrochloride
|
1384430-87-8
|
C10H13ClN4O
|